Botox maker Allergan rejects takeover bid
            
        
            
        
        
        
            Allergan, the US maker of Botox, has rejected a takeover bid from Valeant Pharmaceuticals, saying it "substantially undervalues" the company and questioning the Canadian firm's long-term growth plan.
        
        
        
        
            
                Business
                 • 12 May 14